The 30-second match
Three questions, one computed answer: the quiz filters the 22 verified records by your medication and priority, sorts by all-in price, and shows the winner with its structural tags, the runner-up, and the prepaid path your payment comfort unlocks — the same arithmetic as the rankings, run at your inputs, in your browser.
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
30-second match · computed, not curated
The mechanics, in the open
Priority filters map one-to-one onto record fields: “flat” keeps programs whose price holds across the full titration ladder; “no membership” drops every program with a mandatory platform fee; “named pharmacy” keeps the minority that publish their fulfillment network; “insurance” routes to the coverage-navigation lane, because a covered brand prescription beats every cash figure here; “needle-free” routes to the approved oral pill first and prices the compounded sublingual lane honestly beneath it. The sort is always ascending all-in price at the maintenance basis — the same basis defined in the methodology — and the prepaid line appears only when a published tier exists and your stated comfort covers its term.
What the quiz deliberately cannot do: weight results, feature a sponsor, or output a program whose figure is not in the public dataset with a capture date and source link. Rerun it after any dataset update and the answer moves with the market — which is the point.
Frequently asked
How does the 30-second match work?
Three inputs — medication, top priority, payment comfort — filter and sort the same verified dataset the rankings use, entirely in your browser. The result is the lowest all-in figure matching your filter, with its structural tags and a runner-up, plus the prepaid path where your payment comfort unlocks one. Nothing is weighted, sponsored, or hand-ordered: change an input and watch the sort change.
Is the quiz recommendation medical advice?
No — it is arithmetic on published prices and program structures. Whether a GLP-1 is appropriate for you, which molecule, and at what dose are clinical questions for a licensed prescriber; every program the quiz can output runs its own clinical intake that can say no.
Why does the quiz sometimes point to brand or insurance instead of a compounded program?
Because the data does. Real insurance coverage beats every cash figure in the index, and the FDA-approved oral pill (from $149) is the evidence-backed needle-free benchmark — so the “insurance” and “needle-free” priorities route there first, with the compounded alternatives named beneath.